Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:2042-2048
Published online before print April 2, 2007, doi: 10.1161/CIRCULATIONAHA.106.664219
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
115/15/2042    most recent
CIRCULATIONAHA.106.664219v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Probst, V.
Right arrow Articles by Wilde, A. A.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Probst, V.
Right arrow Articles by Wilde, A. A.M.
Related Collections
Right arrow Electrophysiology
Right arrow Clinical genetics
Right arrow Ion channels/membrane transport
Right arrow Electrocardiology
Right arrow Pediatric and congenital heart disease, including cardiovascular surgery
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Genetics of cardiovascular disease
Right arrowRelated Article

(Circulation. 2007;115:2042-2048.)
© 2007 American Heart Association, Inc.


Pediatric Cardiology

Clinical Aspects and Prognosis of Brugada Syndrome in Children

Vincent Probst, MD, PhD*; Isabelle Denjoy, MD*; Paola G. Meregalli, MD*; Jean-Christophe Amirault, MD; Fréderic Sacher, MD; Jacques Mansourati, MD; Dominique Babuty, MD; Elisabeth Villain, MD; Jacques Victor, MD; Jean-Jacques Schott, PhD; Jean-Marc Lupoglazoff, MD, PhD; Philippe Mabo, MD; Christian Veltmann, MD; Laurence Jesel, MD; Philippe Chevalier, MD; Sally-Ann B. Clur, MD; Michel Haissaguerre, MD; Christian Wolpert, MD; Hervé Le Marec, MD, PhD; Arthur A.M. Wilde, MD, PhD

From L’Institut du Thorax, CHU de Nantes (V.P., J.A., H.L.M.), INSERM U533 (V.P., J.S., H.L.M.), and CIC de Nantes (V.P., J.A., H.L.M.), Nantes, France; Lariboisière Hospital and Centre Cardiologique Infantile (I.D.), Château des Côtes, Les Loges en Josas, France; Department of Cardiology (P.G.M., A.A.M.W.), Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; Service de Cardiologie (F.S., M.H.), Hôpital Cardiologique du Haut Leveque, Bordeaux, France; Service de Cardiologie (J.M.), Centre Hospitalo-Universitaire de Brest, Brest, France; Service de Cardiologie B (D.B.), Hôpital Trousseau, Tours, France; Cardiologie Pédiatrique (E.V.), Hôpital Necker-Enfants Malades, Paris, France; Service de Cardiologie (J.V.), Centre Hospitalo-Universitaire d’Angers, Angers, France; Paediatric Cardiology (J.L.), Robert Debré Hospital, Paris, France; Departement de Cardiologie (P.M.), Hôpital Pontchaillou, Rennes, France; University Hospital Mannheim (C.V., C.W.), University of Heidelberg, Germany; Service de Cardiologie (L.J.), CHU de Strasbourg, Strasbourg, France; Service de Cardiologie (P.C.), CHU de Lyon, Lyon, France; and Department of Paediatric Cardiology (S.B.C.), Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.

Correspondence to Vincent Probst, MD, PhD, Service de Cardiologie du CHU de Nantes, CHU de Nantes, Hôpital Nord, Bd Jacques Monod, 44093 Nantes Cedex, France. E-mail vincent.probst{at}chu-nantes.fr

Received September 20, 2006; accepted December 22, 2006.

Background— Brugada syndrome is an arrhythmogenic disease characterized by an ECG pattern of ST-segment elevation in the right precordial leads and augmented risk of sudden cardiac death. Little is known about the clinical presentation and prognosis of this disease in children.

Methods and Results— Thirty children affected by Brugada syndrome who were <16 years of age (mean, 8±4 years) were included. All patients displayed a type I ECG pattern before or after drug provocation challenge. Diagnosis of Brugada syndrome was made under the following circumstances: aborted sudden death (n=1), syncope of unexplained origin (n=10), symptomatic supraventricular tachycardia (n=1), suspicious ECG (n=1), and family screening for Brugada syndrome (n=17). Syncope was precipitated by fever in 5 cases. Ten of 11 symptomatic patients displayed a spontaneous type I ECG. An implantable cardioverter-defibrillator was implanted in 5 children; 4 children were treated with hydroquinidine; and 1 child received a pacemaker because of symptomatic sick sinus syndrome. During a mean follow-up of 37±23 months, 1 child experienced sudden cardiac death, and 2 children received an appropriate implantable cardioverter-defibrillator shock; all of them were symptomatic and had manifested a type I ECG spontaneously. One child had a cardioverter-defibrillator infection that required explantation of the defibrillator.

Conclusions— In the largest population of children affected by Brugada syndrome described to date, fever represented the most important precipitating factor for arrhythmic events, and as in the adult population, the risk of arrhythmic events was higher in previously symptomatic patients and in those displaying a spontaneous type I ECG.


Key Words: arrhythmia • Brugada syndrome • death, sudden • genetics • ion channels • pediatrics • tachyarrhythmias


Related Article:

Issue Highlights
Circulation 2007 115: 1969. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Br. J. Sports. Med.Home page
R M Campbell, S Berger, and J Drezner
Sudden cardiac arrest in children and young athletes: the importance of a detailed personal and family history in the pre-participation evaluation
Br. J. Sports Med., May 1, 2009; 43(5): 336 - 341.
[Abstract] [Full Text] [PDF]


Home page
ESC Textbook of Cardiovascular MedicineHome page
S. G. Priori, C. Napolitano, S. E. Humphries, and J. Skipworth
CHAPTER 9 Genetics of Cardiovascular Diseases
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. Benito, A. Sarkozy, L. Mont, S. Henkens, A. Berruezo, D. Tamborero, D. Arzamendi, P. Berne, R. Brugada, P. Brugada, et al.
Gender Differences in Clinical Manifestations of Brugada Syndrome
J. Am. Coll. Cardiol., November 4, 2008; 52(19): 1567 - 1573.
[Abstract] [Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Brugada Syndrome in Children
Journal Watch Cardiology, May 16, 2007; 2007(516): 4 - 4.
[Full Text]


Home page
CirculationHome page
S. Viskin
Brugada Syndrome in Children: Don't Ask, Don't Tell?
Circulation, April 17, 2007; 115(15): 1970 - 1972.
[Full Text] [PDF]